← Back to headlines
Novartis Earnings Preview: New Medicines vs. Generic Pressure
An earnings preview for Novartis examines whether new medicines can offset the impact of generic drug pressure and growing U.S. pricing risks on the company's financial performance.
20 Jul, 15:15 — 20 Jul, 15:15
Sources
Showing 1 of 1 sources
